Thermo Fisher expects to sell nearly $2B in Covid tests this year

The Waltham-based life sciences giant expects its Covid-19 testing business to bring in a minimum of $1.75 billion in the 2022 fiscal year — a billion-dollar increase from what the company had originally planned for.